Merck Must Turn Over Docs In Fosamax MDL: Judge
The judge overseeing the multidistrict litigation over the osteoporosis drug Fosamax has ruled that Merck & Co. Inc. must divulge materials dating back to 1998, despite the company's stance against turning...To view the full article, register now.
Already a subscriber? Click here to view full article